Our goal: better therapies through new technology
Established in 1987, STORZ MEDICAL AG is an independent partner company of the KARL STORZ Group. The objective pursued by our physicists and engineers is to continuously improve shock wave technology, to develop new system concepts and to identify new therapy indications in close co-operation with leading medical institutes.
Our products have proved their efficacy in urology in millions of cases. In recent years, their wide spectrum of possibilities and the unique benefits offered by non-invasive shock wave technology has also been extended to other medical disciplines. With its state-of-the-art technological innovations, STORZ MEDICAL is setting new standards in cardiology,neurology, orthopaedics, rheumatology, rehabilitation medicine, aesthetic medicine, dermatology and veterinary medicine.
Pioneering achievements such as the invention of the electromagnetic cylindrical source, the first application of shock waves in cardiac revascularization and combined shock wave therapy (focused, planar and radial shock waves) provide ample proof of the vast performance spectrum of STORZ MEDICAL in the field of shock wave therapy.
In 2018, Transcranial Pulse Stimulation (TPS®) with the NEUROLITH® system was the first of its kind to obtain authorization for the treatment of the central nervous system of Alzheimers patients. Resulting from this success, neurological diseases such as Parkinson, stroke and spinal cord injuries are a focus in our development activities.